Novartis AG: Company Events Publications and Financial Calendar | NOVN | CH0012005267

Chart calendar Novartis AG

46e7.g8FzadO3mTj84FZ9sW4WF_qolBgugA_xr0GxyKXU2BI.2Y0RUePjxnCxvyYJ-lZuL4767SBN62aW2DPk5eGfqiDEjioii_T2cpuPMQ~57e0ad78ff62acfb91bf7663be23df26

Upcoming events on Novartis AG

2025-07-16	Q2 2025 Earnings Release
2025-10-27	Q3 2025 Earnings Release
2026-02-03	Q4 2025 Earnings Release (Projected)
2026-04-27	Q1 2026 Earnings Release (Projected)
2026-07-20	Q2 2026 Earnings Release (Projected)
2026-11-02	Q3 2026 Earnings Release (Projected)

Past events on Novartis AG

2025-06-18	J.P. Morgan European Healthcare Forum
2025-06-17	Citi European Healthcare Conference
2025-06-15 05:00	European Hematology Association Congress - Abstract No.: S312
2025-06-14 12:30	European Hematology Association Congress - Abstract No.: PS1588
2025-06-13 12:30	European Hematology Association Congress - Abstract No.: PF595
2025-06-13 12:30	European Hematology Association Congress - Abstract No.: PF660
2025-06-13 12:30	European Hematology Association Congress - Abstract No.: PF1152
2025-06-13 11:00	European Hematology Association Congress - Abstract No.: S166
2025-06-13 11:00	European Hematology Association Congress - Abstract No.: S183
2025-06-12 11:00	European Hematology Association Congress - Abstract No.: S223
2025-06-11	Commerzbank and ODDO BHF SWISS Equities Conference
2025-06-08	Goldman Sachs Global Healthcare Conference
2025-06-03	Jefferies Healthcare Conference
2025-06-02 16:00	American Society of Clinical Oncology Meeting - Abstract No.: 6501
2025-06-02 10:00	American Society of Clinical Oncology Meeting - Abstract No.: 1069
2025-06-02 10:00	American Society of Clinical Oncology Meeting - Abstract No.: TPS617
2025-06-02 10:00	American Society of Clinical Oncology Meeting - Abstract No.: 527
2025-06-02 10:00	American Society of Clinical Oncology Meeting - Abstract No.: TPS5127
2025-06-01 09:00	American Society of Clinical Oncology Meeting - Abstract No.: 516
2025-05-30 14:00	American Society of Clinical Oncology Meeting - Abstract No.: 6516

Past dividends on Novartis AG

2025-03-10	Annual 3.5 CHF
2024-03-06	Annual 3.3 CHF
2023-03-08	Annual 3.2 CHF
2022-03-07	Annual 3.1 CHF
2021-03-03	Annual 3 CHF
2020-03-02	Annual 2.95 CHF
2019-03-03	Annual 2.85 CHF
2018-03-05	Annual 2.8 CHF
2017-03-01	Annual 2.75 CHF
2016-02-24	Annual 2.7 CHF
2015-03-02	2.6 CHF
2014-02-26	Annual 2.45 CHF
2013-02-25	Annual 2.3 CHF
2012-02-26	Annual 2.25 CHF
2011-02-23	Annual 2.2 CHF
2010-03-01	Annual 2.1 CHF
2009-02-26	Annual 2 CHF
2008-02-28	Annual 1.6 CHF

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	50 545 51 352 -1.57%	45 440 46 810 -2.93%	50 317 50 407 -0.18%	54 293	55 068	56 221
EBITDA Million USD	Released Forecast Spread	18 613 17 036 9.25%	17 937 18 223 -1.57%	21 006 19 819 5.99%	22 517	22 962	23 963
EBIT Million USD	Released Forecast Spread	16 665 16 417 1.51%	16 372 16 735 -2.17%	19 494 18 983 2.69%	20 843	21 124	22 054
Earnings before Tax (EBT) Million USD	Released Forecast Spread	8 371 10 562 -20.74%	9 123 10 323 -11.63%	13 640 13 560 0.59%	16 819	17 213	18 285
Net income Million USD	Released Forecast Spread	6 955 8 563 -18.78%	14 854 10 329 43.8%	11 939 11 438 4.38%	13 827	14 513	15 440
EPS USD	Released Forecast Spread	3,19 4,06 -21.46%	7,15 5,38 32.95%	5,92 5,53 7%	6,95	7,53	8,13
Announcement Date		01/02/23	31/01/24	31/01/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	11 782 11 373 3.6%	11 423 11 773 -2.97%	11 829 11 498 2.88%	12 512 12 319 1.57%	12 823 12 666 1.24%	13 153 12 823 2.57%	13 233 13 050 1.4%	13 936	13 402	13 684	12 285	12 530	12 660	12 525
EBITDA Million USD	Released Forecast Spread		4 224 4 775 -11.55%				5 294
EBIT Million USD	Released Forecast Spread	4 405 4 339 1.52%	3 821 4 094 -6.66%	4 537 4 220 7.52%	4 953 4 667 6.12%	5 145 4 892 5.16%	4 859 4 435 9.56%	5 575 5 272 5.75%	5 764	5 188	4 853	4 955	5 080	5 105	4 575
Earnings before Tax (EBT) Million USD	Released Forecast Spread	1 552 3 240 -52.1%	2 377 3 495 -31.99%	3 129 3 453 -9.38%	3 841 3 896 -1.41%	3 385 4 028 -15.96%	3 285 3 478 -5.55%
Net income Million USD	Released Forecast Spread	1 513 2 786 -45.69%	8 480 6 890 23.08%	2 688 2 459 9.31%	3 246 2 858 13.59%	3 189 3 197 -0.25%	2 820 2 585 9.08%	3 606 3 255 10.78%	3 784	3 332	3 054
EPS USD	Released Forecast Spread	0,73 1,34 -45.68%	4,14 2,87 44.31%	1,31 1,19 10.18%	1,60 1,40 14.13%	1,58 1,48 7.03%	1,42 1,30 9.63%	1,83 1,65 10.96%	1,93	1,71	1,58
Announcement Date		24/10/23	31/01/24	23/04/24	18/07/24	29/10/24	31/01/25	29/04/25	-	-	-	-	-	-	-

Upcoming sector events for Novartis AG

2025-07-09	HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2025-07-15	GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-16 06:45	JOHNSON & JOHNSON: Q2 2025 Earnings Release
2025-07-16	NOVARTIS AG: Q2 2025 Earnings Release
2025-07-16	CAMURUS AB: Q2 2025 Earnings Release
2025-07-17	JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-18 05:00	ORION OYJ: Q2 2025 Earnings Release
2025-07-22	LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected)
2025-07-22	TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected)
2025-07-22	GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Novartis AG

2025-06-17 11:45	MEDINCELL S.A.: Q4 2025 Earnings Release
2025-06-10 04:38	LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release
2025-06-09 04:48	YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release
2025-06-08 20:01	BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release
2025-06-06 04:47	CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release
2025-06-05 04:37	TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release
2025-06-03 04:35	ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release
2025-05-30 09:46	ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release
2025-05-29 07:00	ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release
2025-05-29 04:31	ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release